Ectica Technologies AG

Increasing the predictability of drug testing

Ectica Technologies AG is a tool-providing company serving the pharma, biotech and cosmetic industry in the field of cell culture. We are dedicated to improve hydrogel-based three dimensional (3D) cell culture assays. The company leverages on the patented 3DProSeed technology to create hydrogel-based consumable products that combine the simplicity and automation-compatibility of standard 2D cell culture in microtiter plates with the high biological relevance of cell culture in hydrogels.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No milestones

No Jobs

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (10'000) 2014

Website

UZH Spin-off

UZH Spin-off 2015

Website

Ectica Technologies AG

Increasing the predictability of drug testing

Website:
www.ectica-technologies.com

Headquarter:
Zürich

Foundation Date:
March 2015

Technology:

  • Biotech

Sectors:

  • Biomaterials
  • Biotech
  • Drug development platforms
  • Screening

Support received

  • Support venturekick